Gansu granule in the treatment of compensated cirrhosis of hepatitis B study random parallel control

QIN song
DOI: https://doi.org/10.3969/j.issn.1671-7813.2013.07(s).37
2013-01-01
Abstract:[Objective]Observation of Gansu granule in the treatment of compensated cirrhosis of hepatitis B.[Methods]Using randomized controlled methods,150 cases of inpatients and outpatients were randomly divided into two groups of numbers. A control group of 75 cases of liver protecting tablet,1.44g/,3 /d,oral+ compound Yigan,1.28g/,3 /d,oral. The treatment group of 75 liver Sue particles,20g/,sooner or later oral. Two sets of continuous treatment with 30d for 1 courses. Observation of clinical symptoms,B ultrasound,HBV-M index,HBV-DNA level changes,adverse reaction. Continuous treatment of 2 courses(60d),curative effect. 49 cases of group therapy[Results],15 cases were effective,11 cases ineffective,the total efficiency of85.33%. 20 cases of control group,24 cases effective,31 cases ineffective,the total efficiency of 58.67%. The clinical effect of the treatment group than in control group(P< 0.01). Treatment group was better than control group B ultrasound index(P< 0.05). Treatment group were negative in 24 cases,negative conversion rate was 57.10%,control group 13 cases were negative,negative conversion rate is 32.50%,the treatment group than the control group(P< 0.05). Serum level of HBV-DNA in two group were improved(P< 0.05),the treatment group was better than the control group(P< 0.05).[Conclusion]Gansu granule in the treatment of compensated cirrhosis of hepatitis B effect is significant,worthy of popularization.
What problem does this paper attempt to address?